{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:06:42Z","timestamp":1790431602744,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health &amp; Welfare, Republic of Korea","award":["HI19C1330"],"award-info":[{"award-number":["HI19C1330"]}]},{"name":"National Research Foundation of Korea Grant","award":["No. NRF-2019R1A2C1085958"],"award-info":[{"award-number":["No. NRF-2019R1A2C1085958"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>There are no means to predict patient response to neoadjuvant chemotherapy (NAC); the impact of skeletal muscle loss on the response to NAC remains undefined. We investigated the association between response to chemotherapy and skeletal muscle loss in breast cancer patients. Patients diagnosed with invasive breast cancer who were treated with NAC, surgery, and radiotherapy were analyzed. We quantified skeletal muscle loss using pre-NAC and post-NAC computed tomography scans. The response to treatment was determined using the Response Evaluation Criteria in Solid Tumors. We included 246 patients in this study (median follow-up, 28.85 months). The median age was 48 years old (interquartile range 42\u201354) and 115 patients were less than 48 years old (46.7%). Patients showing a complete or partial response were categorized into the responder group (208 patients); the rest were categorized into the non-responder group (38 patients). The skeletal muscle mass cut-off value was determined using a receiver operating characteristic curve; it showed areas under the curve of 0.732 and 0.885 for the pre-NAC and post-NAC skeletal muscle index (p &lt; 0.001 for both), respectively. Skeletal muscle loss and cancer stage were significantly associated with poor response to NAC in locally advanced breast cancer patients. Accurately measuring muscle loss to guide treatment and delaying muscle loss through various interventions would help enhance the response to NAC and improve clinical outcomes.<\/jats:p>","DOI":"10.3390\/cancers13081806","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T03:04:06Z","timestamp":1618196646000},"page":"1806","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-9773","authenticated-orcid":false,"given":"Byung Min","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-0880","authenticated-orcid":false,"given":"Yeona","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-364X","authenticated-orcid":false,"given":"Jun Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-9686","authenticated-orcid":false,"given":"Sung Gwe","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-8540","authenticated-orcid":false,"given":"Jee Hung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hei Cheul","family":"Jeung","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0397-0005","authenticated-orcid":false,"given":"Joon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Jae","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/1097-0142(19940115)73:2<362::AID-CNCR2820730221>3.0.CO;2-L","article-title":"Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast","volume":"73","author":"Schwartz","year":"1994","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D","article-title":"Management of stage iii primary breast cancer with primary chemotherapy, surgery, and radiation therapy","volume":"62","author":"Hortobagyi","year":"1988","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from national surgical adjuvant breast and bowel project b-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejso.2011.07.003","article-title":"Surgery following neoadjuvant therapy in patients with her2-positive locally advanced or inflammatory breast cancer participating in the neoadjuvant herceptin (noah) study","volume":"37","author":"Semiglazov","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","volume":"54","author":"Mazurak","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.hpb.2019.10.1532","article-title":"Low thoracic muscle radiation attenuation is associated with postoperative pneumonia following partial hepatectomy for colorectal metastasis","volume":"22","author":"Rensen","year":"2020","journal-title":"HPB Oxf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.compmedimag.2019.04.007","article-title":"Muscle segmentation in axial computed tomography (ct) images at the lumbar (l3) and thoracic (t4) levels for body composition analysis","volume":"75","author":"Dabiri","year":"2019","journal-title":"Comput. Med. Imaging Graph."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised recist guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20140142","DOI":"10.1259\/bjr.20140142","article-title":"Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: Usefulness of breast mri computer-aided detection","volume":"87","author":"Kim","year":"2014","journal-title":"Br. J. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jso.21424","article-title":"The role of pet ct to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: Comparison with ultrasonography and magnetic resonance imaging","volume":"102","author":"Choi","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.21037\/atm.2019.10.34","article-title":"Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer","volume":"7","author":"Lin","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1245\/s10434-019-07655-7","article-title":"A nomogram to predict the pathologic complete response of neoadjuvant chemotherapy in triple-negative breast cancer based on simple laboratory indicators","volume":"26","author":"Zhang","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-07-4756","article-title":"Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes","volume":"14","author":"Desmedt","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"163","author":"Goorts","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jnci\/82.19.1539","article-title":"Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more","volume":"82","author":"Bonadonna","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jso.10090","article-title":"Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer","volume":"80","author":"Gajdos","year":"2002","journal-title":"J. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-05-0042","article-title":"Obesity and outcomes in premenopausal and postmenopausal breast cancer","volume":"14","author":"Loi","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.01.079","article-title":"Weight, weight gain, and survival after breast cancer diagnosis","volume":"23","author":"Kroenke","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","article-title":"The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer","volume":"17","author":"Parsons","year":"2012","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1200\/JCO.2007.14.4527","article-title":"Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer","volume":"26","author":"Litton","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2009.12.012","article-title":"Ethnic differences in body composition and the associated metabolic profile: A comparative study between asians and caucasians","volume":"65","author":"Wulan","year":"2010","journal-title":"Maturitas"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jso.23959","article-title":"The prognostic significance and relationship with body composition of ccr7-positive cells in colorectal cancer","volume":"112","author":"Malietzis","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e172319","DOI":"10.1001\/jamaoncol.2017.2319","article-title":"Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: Results from the c scans study","volume":"3","author":"Feliciano","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1200\/JCO.2014.55.4261","article-title":"Incorporating biomarkers into cancer and aging research","volume":"32","author":"Hubbard","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0300891618792476","article-title":"Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy","volume":"105","author":"Kim","year":"2019","journal-title":"Tumori J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/1759-7714.12838","article-title":"Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer","volume":"9","author":"Takeda","year":"2018","journal-title":"Thorac. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s00520-020-05477-y","article-title":"The role of inflammation in adjuvant chemotherapy-induced sarcopenia (izmir oncology group (izog) study)","volume":"28","author":"Oflazoglu","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-016-5360-7","article-title":"Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer","volume":"23","author":"Chemama","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","first-page":"40","article-title":"Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer","volume":"101","author":"Tan","year":"2014","journal-title":"Brit. J. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fonc.2018.00457","article-title":"Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy","volume":"8","author":"Cho","year":"2018","journal-title":"Front. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/8\/1806\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:59:18Z","timestamp":1760363958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/8\/1806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cancers13081806"],"URL":"https:\/\/doi.org\/10.3390\/cancers13081806","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}